Literature DB >> 18162323

Secretion of DJ-1 into the serum of patients with Parkinson's disease.

Chinatsu Maita1, Sachiko Tsuji, Ichiro Yabe, Shinsuke Hamada, Akihiko Ogata, Hiroyhsi Maita, Sanae M M Iguchi-Ariga, Hidenao Sasaki, Hiroyoshi Ariga.   

Abstract

DJ-1 was initially identified by us as a novel oncogene and has later been found to be a causative gene for familial Parkinson's disease PARK7. DJ-1 plays role in transcriptional regulation and in oxidative stress function, and loss of its function is thought to be related to onset age, mode of progression and clinical severity of both familial and sporadic forms of Parkinson's disease (PD). DJ-1 is localized both in the cytoplasm and nucleus, and it has been reported to be secreted into the serum or plasma of patients with breast cancer, melanoma, familial amyloidotic polyneuropathy and stroke. In this study, levels of DJ-1 secreted into the serum of healthy controls and patients with sporadic PD were examined by using a DJ-1 ELISA kit, and the level of oxidative stress in the serum was also measured. The results showed that DJ-1 was secreted into the serum of both healthy controls and PD patients. There was no significant difference between the levels of secreted DJ-1 in two groups, and correlations of levels of secreted DJ-1 with age, clinical severity of PD and level of oxidative stress were not found.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162323     DOI: 10.1016/j.neulet.2007.11.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  35 in total

1.  High levels of DJ-1 protein in nipple fluid of patients with breast cancer.

Authors:  Miki Oda; Masujiro Makita; Keiichi Iwaya; Futoshi Akiyama; Norio Kohno; Benio Tsuchiya; Takuji Iwase; Osamu Matsubara
Journal:  Cancer Sci       Date:  2012-04-04       Impact factor: 6.716

Review 2.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 4.  Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.

Authors:  Luis F Gonzalez-Cuyar; Joshua A Sonnen; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 5.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

6.  Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Authors:  Min Shi; Cyrus P Zabetian; Aneeka M Hancock; Carmen Ginghina; Zhen Hong; Dora Yearout; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; James B Leverenz; Jing Zhang
Journal:  Neurosci Lett       Date:  2010-06-09       Impact factor: 3.046

7.  DJ-1 mRNA anatomical localization and cell type identification in the mouse brain.

Authors:  Zhiguo Xie; Xiaoxi Zhuang; Linan Chen
Journal:  Neurosci Lett       Date:  2009-09-17       Impact factor: 3.046

Review 8.  Biomarker discovery in neurodegenerative diseases: a proteomic approach.

Authors:  Min Shi; W Michael Caudle; Jing Zhang
Journal:  Neurobiol Dis       Date:  2008-09-26       Impact factor: 5.996

9.  Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury.

Authors:  Takashi Yanagida; Jun Tsushima; Yoshihisa Kitamura; Daijiro Yanagisawa; Kazuyuki Takata; Tomonori Shibaike; Atsuko Yamamoto; Takashi Taniguchi; Hiroyuki Yasui; Takahiro Taira; Shigehiro Morikawa; Toshihiro Inubushi; Ikuo Tooyama; Hiroyoshi Ariga
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

10.  Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.

Authors:  Koichiro Yamane; Yoshihisa Kitamura; Takashi Yanagida; Kazuyuki Takata; Daijiro Yanagisawa; Takashi Taniguchi; Takahiro Taira; Hiroyoshi Ariga
Journal:  Int J Mol Sci       Date:  2009-11-05       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.